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Abstract
Background: To describe the demographic and geographic distribution of tuberculosis (TB) in
Manitoba, thus determining risk factors associated with clustering and higher incidence rates in
distinct subpopulations.
Methods: Data from the Manitoba TB Registry was compiled to generate a database on 855
patients with tuberculosis and their contacts from 1992–1999. Recovered isolates of M. tuberculosis
were typed by IS6110 restriction fragment length polymorphisms. Bivariate and multivariate logistic
regression models were used to identify risk factors involved in clustering.
Results: A trend to clustering was observed among the Canadian-born treaty Aboriginal subgroup
in contrast to the foreign-born. The dominant type, designated fingerprint type 1, accounts for
25.8% of total cases and 75.3% of treaty Aboriginal cases. Among type 1 patients residing in urban
areas, 98.9% lived in Winnipeg. In rural areas, 92.8% lived on Aboriginal reserves. Statistical models
revealed that significant risk factors for acquiring clustered tuberculosis are gender, age, ethnic
origin and residence. Those at increased risk are: males (p < 0.05); those under age 65 (p < 0.01
for each age subgroup); treaty Aboriginals (p < 0.001), and those living on reserve land (p < 0.001).
Conclusion: Molecular typing of isolates in conjunction with contact tracing data supports the
notion of the largest ongoing transmission of a single strain of TB within the treaty-status
population of Canada recorded to date. This data demonstrates the necessity of continued
surveillance of countries with low prevalence of the disease in order to determine and target high-
risk populations for concentrated prevention and control measures.
Background
Tuberculosis (TB) has infected one-third of the world
population and kills three million people each year. Glo-
bally, TB is considered the most common cause of death
from a single infectious organism, Mycobacterium tubercu-
losis  [1–3]. Canadians have a long history of suffering
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tremendously from TB. In the 19th century, one fifth of
Canadians were infected with this disease and large num-
bers died. In the beginning of the 20th century, the mortal-
ity rate among Aboriginal people of Saskatchewan and
Alberta reached as high as 9,000 per 100,000 [4,5].
Improvements in socioeconomic conditions, public
health services, drug therapy and medical surveillance in
Canada markedly reduced the mortality rate [0.4 per
100,000 by 1987] and overall incidence rates (5.9 per
100,000 by 1998) [6]. However, certain groups in Canada
are at higher risk for acquiring TB, such as the Aboriginal
population (defined as status and non-status Indian,
Metis, Inuit, and Innu), foreign-born individuals from
countries with high prevalence rates of TB, the homeless
and the HIV-infected population [6]. In 1998, the inci-
dence rate among non-Aboriginal Canadians was 1.5 per
100,000; in contrast, the status Indian, total Aboriginal
and foreign-born population had incidence rates of 35.4,
22.5 and 21.4 per 100,000 respectively [7]. Furthermore,
the proportion of TB cases reported in Canada from the
foreign-born population has increased, from 35% in 1980
to 64% in 1998 [7]. In an attempt to eliminate tuberculo-
sis in Canada, the Tuberculosis Prevention and Control
Unit of Health Canada implemented guidelines recom-
mended by the World Health Organization in 1997 [6].
Despite adoption of these guidelines, incidence rates of
TB are still high in certain geographic and demographic
zones, making elimination of the disease by recom-
mended time periods put forth by Health Canada an
increasingly difficult goal [6,8]. Currently, incidence rates
in Canada have leveled off and remain fairly constant due
to these sustaining population subgroups.
The majority (75%) of TB patients in Canada live in three
provinces: Ontario, Quebec and British Columbia. Fur-
thermore, 90% of all TB cases in the country attributed to
the foreign-born population reside in these provinces [9].
In Manitoba however, the composition of TB patients is
distinctly different: the majority of TB cases are among
Canadian-born, with the highest incidence among treaty
Aboriginals (48.4 per 100,000 overall, with rates as high
as 496.3 per 100,000 in select communities [10,11].
These distinct epidemiological patterns merited a further
examination. Consequently, in this study, both conven-
tional in conjunction with molecular methods were used
to describe the epidemiology of tuberculosis in Manitoba
from 1992 to 1999. The objectives of the study were to
describe subgroups within Manitoba at high risk for
developing TB, and to define risk factors and possible rea-
sons for the ongoing transmission in order to better target
prevention and control programs.
Methods
Setting
Manitoba has a population of 1.14 million (Statistics
Canada, 1996). 78.1% are Canadian-born (CB) non-
treaty, 8.9% are treaty Aboriginals, and the remainder is
foreign-born (FB) [12,13]. It is unknown how many Abo-
riginal individuals have not claimed treaty status. All diag-
nosed cases of tuberculosis in Manitoba are registered in
the Manitoba Central Tuberculosis Registry (MCTR) at the
Health Sciences Center (HSC) in Winnipeg. Case finding
in Manitoba is done by clinical diagnosis of symptomatic
patients and by contact tracing. Administered treatment is
drug therapy of a combination of first line antituberculo-
sis drugs: rifampin, isoniazid, pyrazinamide, ethambutol,
and/or streptomycin. Direct observed therapy (DOT) ver-
ifies a completed course of treatment. Ninety-five percent
of patients under DOT complete treatment in Manitoba
[8].
Sample Data
Data on all TB patients and identified contacts from Janu-
ary 1, 1992 to December 31, 1999 was obtained from the
MCTR. Data fields such as the patient's unique identifier
number, date of birth, birthplace, sex, country of birth,
postal code, origin (CB treaty / non-treaty or FB), date of
diagnosis, case finding method, TB status (new, active or
relapse), BCG status, year of landing (foreign patients),
smear results, culture results, TB DNA fingerprint type,
drug resistance, chest X-rays and cavity status were
extracted from the patient records and the information
was entered into a database. This data set did not include
patient name, allowing data analysis while maintaining
the patient confidentiality. Specimens were collected by
designated medical staff at the Respiratory Clinic, HSC,
and other health care centers in Manitoba. The collected
samples were sent to the Clinical Microbiology Labora-
tory at HSC for isolation and identification of M. tubercu-
losis. The Accuprobe M. tuberculosis complex kit (Gen-
Probe Incorporated, San Diego, CA, USA) was used to
identify M. tuberculosis in the clinical samples. Samples
were subsequently processed for DNA sub-typing accord-
ing to the internationally standardized methodology of
IS6110  restriction fragment length polymorphisms
(RFLP) [14]. Procedures outlined by Small et. al. to mini-
mize the possibility of cross-contamination [15] was
strictly adhered to by staff at the HSC and no evidence of
cross-contamination was observed.
RFLP Analysis
All gel pictures containing the IS6110 RFLP patterns were
analyzed to determine clustering using Molecular Analyst®
Software Fingerprinting version 1.12, BioRad, Hercules,
CA, USA. Clustering establishes groups of patients from
which isolates with identical or near identical fingerprints
are found and are likely to be linked epidemiologicallyBMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/18
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[16]. Clustered cases were identified by searching each fin-
gerprint against the created database containing all other
patterns over the eight-year period using the Dice coeffi-
cient with 1.5% position tolerance and verified visually.
Isolates with identical patterns or differing by a single
band were considered the same [17]. All created databases
were stored in Microsoft Access® and linked together uti-
lizing the MCTR unique identifier numbers.
Statistical Analysis
Population figures from the 1996 Statistics Canada Cen-
sus were used to calculate tuberculosis incidence rates.
Since the study was conducted over an eight-year period,
the person-year population of Manitoba throughout this
time was determined by multiplying the 1996 population
by eight. To determine the incidence rate for a specific
population subgroup, we added all TB cases in that sub-
group from 1992 to 1999 then divided by the total eight-
year subgroup person-years. The resulting number was
multiplied by 100,000 to obtain the incidence rate per
100,000 person-years. To compare risk factors for recent
TB acquisition of the subpopulation of interest, we used
clustering versus non-clustering (unique) as the outcome
variable. Bivariate and multivariate logistic regression
analyses were carried out using NCSS 2000 software
(NCSS, Kaysville, UT, USA). Variables used in the bivari-
ate model (table 1) were gender, age (five subgroups), eth-
nic origin (three subgroups), residence (four subgroups)
and site of infection. A chi-squared test for linear trend
was performed on the subgroups. Multivariate models
using gender, age, ethnic origin, residence, site of infec-
tion, status (new or relapse), drug resistance, BCG status,
chest x-ray and cavity were analyzed and potential interac-
tions were assessed for significance. Variables significant
at the p < 0.05 level were kept in the final multivariate
model, summarized in Table 2.
Results
Tuberculosis Trends
Between January 1st 1992 and December 31st 1999, there
were 855 reported cases of tuberculosis in Manitoba. The
majority of individuals with tuberculosis were born in
Canada (70.6%) and almost half of the total patients were
CB with treaty status (44.4%). Non-treaty CB individuals
contributed 26.2% of total cases and FB population con-
tributed 29.4% (figure 3).
The age distribution of TB cases varies between the three
population subgroups. For the treaty status subgroup, the
incidence in the oldest (65+) age group was 17.3 times
that in the youngest (0–14) age group, whereas this ratio
Table 1: Bivariate logistic regression analysis of risk factors associated with clustering.
Characteristic Incidence Clustered Non-Clustered Odds Ratio p value
(person-year/100 000) n = 426 (%) n = 203 (%) (95%) CI
Sex
Female 8.4 167 (39.2) 102 (50.2) 1 (reference)
Male 10.1 259 (60.8) 101 (49.8) 1.57 (1.12–2.19) 0.011
Age *
0 to 14 3.1 18 (4.2) 4 (2.0) 4.61 (1.39–16.84) 0.004
15 to 24 5.8 51 (12.0) 17 (8.4) 3.07 (1.58–6.03) 0.000
25 to 44 10.4 170 (39.9) 47 (23.1) 3.70 (2.33–5.89) 0.000
45 to 64 10.7 102 (23.9) 48 (23.6) 2.17 (1.35–3.52) 0.000
65 + 18.4 85 (20.0) 87 (42.9) 1
Origin
Canadian-Born (non-treaty) 3.3 97 (22.8) 60 (29.6) 1
Canadian-Born (treaty) 48.4 254 (59.6) 27 (13.3) 5.82 (3.46–9.54) 0.000
Foreign-Born 20 75 (17.6) 116 (57.1) 0.340 (0.261–0.620) 0.000
Residence
Winnipeg 9.7 235 (55.1) 153 (75.4) 1
other urban 4.1 14 (3.3) 11 (5.4) 0.829 (0.369–1.829) 0.809
reserves 33.7 148 (34.7) 15 (7.4) 6.424 (3.563–
10.947)
0.000
other rural 9.2 29 (6.9) 24 (11.8) 0.787 (0.443–1.392) 0.051
Site of Infection
Extrapulmonary 111 (26.1) 66 (32.5) 1
Pulmonary 315 (73.9) 137 (67.5) 1.367 (0.951–1.969) 0.112
* χ2 test for overall linear trend in age = 32.6, p < 0.001BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/18
Page 4 of 11
(page number not for citation purposes)
was 10.9 for the non-treaty population, and only 1.3 for
the foreign-born population (Figure 3).
Dividing Manitoba into rural and urban categories indi-
cates that the majority of FB individuals and non-treaty
Canadians with TB reside within the city of Winnipeg,
while the majority of treaty-status individuals with TB
reside in rural areas (figure 1). Winnipeg, as the major
urban center of Manitoba, hosts 98.4% of all FB TB
patients, and 62.8% of total patients. Aboriginal reserve
land includes 22.1% (189) of total patients, with nine
reserves in northern Manitoba harboring 159 (84%) of
these cases. The TB incidence rate per 100,000 person-
years for these nine isolated communities ranged from
19.9 to 496.3 per community. Almost all of these cases
were in registered treaty individuals. The remaining
15.1% of total patients live in urban areas other than Win-
nipeg and rural areas other than reserves. Individuals liv-
ing in urban places other than Winnipeg or rural areas
other than reserves experienced a rate of only 4.1 per
100,000 person-year. The overall Winnipeg incidence rate
(9.7 per 100,000 person-years) was comparable to the
overall Manitoba's rate (9.2 per 100,000 person-years).
Molecular typing and clustering of cases
Isolates of M. tuberculosis were obtained from a total of
629 patients (73.6%) for molecular typing to establish
clustering. The remaining balance of cases were diagnosed
by means other than microbiological and thus no culture
was available for sub-typing. The patient characteristics of
these unavailable isolates were compared to those availa-
ble to observe any significant differences that may affect
estimation of clustering. The distribution of patients was
roughly the same for both and was deemed not signifi-
cant. Fingerprint patterns of less than six RFLP bands were
observed in 15 isolates. These fingerprints did not cluster,
and therefore secondary sub-typing of these isolates, i.e.
spoligotyping, was not performed [16].
In total, 249 different fingerprints were obtained, and 203
of them were unique. The 46 that were not unique formed
clusters that linked patients into groups containing as lit-
tle as two and as many as 162 individuals per cluster. The
dominant fingerprint type over the study period was fin-
gerprint type 1 (FP1), a strain containing a 12-band
IS6110 pattern that was tested sensitive to primary drugs.
This strain afflicted 162 (25.8%) individuals of the total
TB population, with a very high proportion of treaty indi-
viduals (75.3%) residing in both Winnipeg and reserves
being infected. By contrast, the second most frequent
fingerprint is type 2, infecting only 32 (5.1%) of the total
population with TB. The top five fingerprint patterns in
terms of prevalence are distributed as seen in figure 5.
The distribution of clustering by the distinct sub-popula-
tions is also graphically represented in figure 4. The treaty
Table 2: Multivariate logistic regression analysis of risk factors associated with clustering
Characteristic Incidence Clustered Non-Clustered 
(unique)
Odds Ratio p value
(person-year/100 000) n = 426 (%) n = 203 (%) (95%) CI
Sex
Female 8.4 167 (39.2) 102 (50.2) 1 (reference)
Male 10.1 259 (60.8) 101 (49.8) 1.959 (1.306–2.938) 0.0011
Age *
0 to 14 3.1 18 (4.2) 4 (2.0) 2.55 (0.74–8.88) 0.1401
15 to 24 5.8 51 (12.0) 17 (8.4) 2.53 (1.20–5.34) 0.0151
25 to 44 10.4 170 (39.9) 47 (23.1) 3.26 (1.92–5.54) 0.0000
45 to 64 10.7 102 (23.9) 48 (23.6) 1.47 (0.87–2.50) 0.1523
65 + 18.4 85 (20.0) 87 (42.9) 1
Origin†
Canadian-Born (non-treaty) 3.3 97 (22.8) 60 (29.6) 1
Canadian-Born (treaty) 48.4 254 (59.6) 27 (13.3) 4.108 (2.163–7.803) 0.0000
Foreign-Born 20.0 75 (17.6) 116 (57.1) 0.248 (0.149–0.412) 0.0000
Residence‡
Winnipeg 9.7 235 (55.1) 153 (75.4) 1
other urban 4.1 14 (3.3) 11 (5.4) 0.490 (0.195–1.230) 0.1289
reserves 33.7 148 (34.7) 15 (7.4) 1.206 (0.546–2.665) 0.6433
other rural 9.2 29 (6.9) 24 (11.8) 0.410 (0.203–0.830) 0.0132
* age overall effect, χ2 test = 21.83 with 4 different factors, p < 0.001 † origin overall effect, χ2 test = 81.54 with 2 different factors, p < 0.001 ‡ 
residence overall effect, χ2 test = 9.26 with 3 different factors, p < 0.05BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/18
Page 5 of 11
(page number not for citation purposes)
subpopulation contributed 254 (59.6%) of clustered
cases; in contrast, the FB population comprised the major-
ity of unique cases (57.2%). Comparison of clustering
among geographical subgroups also showed the highest
proportion of clustering among the reserves and Winni-
peg. Of the 162 FP1 cases, 93 (57.4%) lived in urban
areas, and of these, 98.9% were in Winnipeg. Of the 69
(42.6%) living in rural areas, 92.8% resided on reserve
land. Furthermore, Winnipeg presented the majority of
unique fingerprint types, due to the large proportion of
foreign-born persons residing in the city.
Risk Factor Analysis
Analysis of risk factors for clustering using both bivariate
and multivariate analysis is summarized in tables 1 and 2.
Significant independent risk factors for clustering
included gender, age, geographic residence and ethnic ori-
gin. Males are twice as likely to develop clustered TB than
females (table 2). Treaty status patients are at four times
higher risk of developing clustered TB than those without
treaty status (reference subgroup), while in comparison,
foreign-born patients are at one-quarter the risk for devel-
oping clustered TB compared to the reference population.
TB patients in the four age groups under age 65 had risks
of developing clustered TB that ranged from 1.5 to 3.3
times that of those over the age of 65 (table 2). Residence
on a reserve was significant in the bivariate analysis: these
patients have a five times higher risk of having clustered
TB than the patient group that lives in Winnipeg. In the
multivariate model, however, controlling for the other
variables revealed that residence is not a significant inde-
pendent risk factor, although living in a rural non-reserve
area is protective (table 2). Finally, there was no evidence
that patients with pulmonary TB had a higher risk of
developing clustered TB than those with extra pulmonary
TB.
Tuberculosis incidence rates by age group and origin, 1992–1999 Figure 3
Tuberculosis incidence rates by age group and origin, 1992–1999.
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Contact Tracing
The largest cluster contained 162 cases that displayed FP1.
Contact investigations were indicated on 121 of these
cases, determining a total of 2195 contacts. 145 of those
contacts presented with disease. Of the 145 contacts, 92
(63.5%) harbored the FP1 strain of TB. 4 (2.8%) had a fin-
gerprint type other than FP1, and the remainder of cases
did not have isolates available for typing purposes. Most
exposures were from family members (57.5%)or friends
(24.5%) in the home (71.7%). Preliminary social network
analysis using software packages Ucinet and Pajek
revealed the spread of TB from Winnipeg to reserve land
and vice versa.
Discussion
The end of World War II marked the beginning of a sharp
decline in TB incidence rates in Canada. Unfortunately,
the last 10 years have shown a leveling off of total inci-
dence rates at approximately 7 per 100,000, with no
appreciable decline (figure 2) [6,7,9]. Manitoba shares the
same national trends [7,10]. Although rates have declined
in every subpopulation, comparative rates among CB
treaty individuals in Manitoba (48.4 per 100,000) are still
more than ten times than those of the non-treaty sub-
group (3.3 per 100,000), and more than two times those
of the FB subgroup (22.0 per 100,000) (figure 3)
[10,11,18]. Furthermore, whereas the overall majority of
TB cases in Canada are attributed to immigration, the
population distribution of tuberculosis in Manitoba is
distinctly different than in the other provinces. While for-
eign-born cases represent 81% of Ontario TB patients,
48% of Quebec TB patients and 60% of TB patients in
British Columbia, in contrast, they represent only 29% of
the total TB cases in Manitoba between 1992 and 1999
Geographic distribution of tuberculosis patients in Manitoba, 1992–1999 Figure 1
Geographic distribution of tuberculosis patients in Manitoba, 1992–1999. Top chart represents rural Manitoba, in contrast, the 
bottom depicts urban Manitoba.
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[9,18]. It is well established that the foreign-born and
Aboriginal groups seem more susceptible to tuberculosis
than others within Canada [6,9]. In Manitoba, however,
these sub-populations are sustaining the steady level of
incidence. Our data demonstrates that TB in Manitoba is
a multifaceted problem that can be examined in two
distinct, parallel categories. These categories are Canadian
TB, where the source of the strains and the patients is
Canadian, and foreign TB, where both the patients and
strains are from outside Canada.
The major single contributor to the current burden of inci-
dent cases is the treaty status subpopulation. The treaty
subgroup, with 44.4% of all tuberculosis cases in Mani-
toba, comprises the largest group of cases, despite the fact
that they represent only 8.9% of Manitoba's population.
This figure is probably an underestimate of all Aboriginal
cases due to an unknown number of Aboriginal individu-
als who have not claimed treaty status. Moreover, the
incidence rate of TB among the treaty status population
(48.4 per 100,000) was higher than both the provincial
rate (9.2 per 100,000) and the national rate of (5.9 per
100,000) by five and eight times respectively. Certain
northern First Nation communities have TB incidence
rates that are markedly elevated (up to 496.3 per 100 000
person-years). Statistical analysis showed the treaty sub-
group to be at relatively high risk for the development of
TB, with significant independent risk factors for clustering
to include male gender, treaty status, and under age 65.
More than 75% of the treaty status population group was
clustered together by the FP1 strain. Contact tracing
revealed only 92 (57%) confirmed epidemiological links
within this cluster, living in both Winnipeg and reserve
land. Although using both molecular and conventional
techniques verifies that linked cases are most likely linked,
Distribution of the top five prevalent fingerprint types by (a) population subgroup and (b) geographic subgroup, 1992–1999 Figure 5
Distribution of the top five prevalent fingerprint types by (a) population subgroup and (b) geographic subgroup, 1992–1999.
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there are limitations to using these techniques [19].
Firstly, transmission can occur through brief, casual con-
tacts, leading to patients having the same fingerprint
pattern, yet no definable connection. Secondly, identical
RFLP patterns can be obtained from patients that are not
linked through recent transmission/reinfection, but due
to reactivation. Thirdly, the strain can be inherent in a
population, with an unidentifiable source.
However, as clustering is assumed to reflect recent trans-
mission within in a population [16,19], supported by the
considerable transmission between family and friends as
illustrated by contact investigations, it is highly probable
that there is an ongoing, propagating TB outbreak in this
subpopulation. The presence of a high percentage of res-
piratory tuberculosis cases and the large number of posi-
tive smear results (data not shown) among FP1 patients
suggests that TB in this population subgroup may be
transmitted more efficiently than in other subgroups.
Potential factors contributing to increased risk in this sub-
population include: relative poverty, crowded housing,
dense social networks, delays in diagnosis and treatment,
increased susceptibility to infection due to poorer health
status, and increased prevalence of substance abuse. Data
on these variables was not available for analysis in the
present study. In addition, while the HIV positive group
was emerging as an at-risk group for TB in the US, it has
not yet been recognized as a risk group in Canada [20].
Thus, the HIV status of tuberculosis patients was not rou-
tinely determined in Manitoba until 1997; therefore,
complete data on this variable was not available for the
current study [21].
The reason for the dominance of FP1 remains unknown,
although it has been speculated that perhaps this strain
was the first strain introduced to Manitoba. Host genetics,
Clustering of fingerprint patterns for (a) population subgroups, (b) geographic subgroups, 1992–1999 Figure 4
Clustering of fingerprint patterns for (a) population subgroups, (b) geographic subgroups, 1992–1999.
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strain virulence or a combination thereof may play a role
[22,23]. Routine BCG administration to treaty status
infants could have further fostered the natural selection of
FP1 by increasing body protection against other suscepti-
ble strains through selective immunity. While it is difficult
to disentangle social, economic and host risk factors from
our analysis, we speculate that this particular strain may
be more virulent than other strains introduced to the pop-
ulation. It is possible that this strain shares some features
in common with putatively 'hyper virulent' strains CDC
1551 and/ or HN878 [24,25]. Bacterial virulence factors,
their expression, regulation and mutation, and host
immune system evasion mechanisms may play a role, and
this remains to be studied [23].
Winnipeg and nine Aboriginal reserves of northern Mani-
toba appear to be the two reservoirs that maintain the
bulk of clustered TB cases. Patients on reserves were found
more than six times as likely to have clustered TB
compared to patients in Winnipeg using bivariate analy-
sis. Sixty percent of Manitoba's entire population lives in
Winnipeg and there is considerable mobility between
Winnipeg and the reserve communities. Since neither
geography nor physical distance can provide a barrier to
stop the spread of this disease, the types of contact rela-
tionships are important factors in elucidating the spread
of TB and differentiating active transmission versus
reactivation.
The epidemiological separation between CB and FB tuber-
culosis cases is the result of many different characteristics.
The dominance of unique (non-clustered) fingerprints
among foreign-born individuals suggests that these
patients may have contracted the disease outside the prov-
ince and have subsequently imported tuberculosis into
Manitoba through immigration. This was found true of
Reported new active and relapsed tuberculosis cases and incidence rate per 100,000 – Canada: 1928–1998 Figure 2
Reported new active and relapsed tuberculosis cases and incidence rate per 100,000 – Canada: 1928–1998.
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imported TB in province of Alberta [26]. The age distribu-
tion of cases in the foreign-born subgroup reflects the age
distribution of immigrants, some of whom for unknown
reasons progress to active TB after arrival into Canada.
New arrivals into the country may for some time have lim-
ited close contact with Canadian-born individuals, which
reduces the chance of spread from immigrants to the CB
population. The small amount of clustering that does
occur in the FB subpopulation may be explained largely
by activation of infections acquired from common
sources in the foreign country of origin. In Manitoba, FB
TB patients reside largely in the Winnipeg area and spread
of the disease from FB patients to CB individuals is very
limited (data not shown).
While the foreign-born population may not seem to be
actively spreading TB in Manitoba, incidence rates are still
relatively high, and the number of FB cases reported annu-
ally is increasing. Screening procedures for immigrating
individuals from countries with high or low prevalence of
TB need further examination for effectiveness and cost-
effectiveness [27].
In the present study, information derived from both con-
ventional and molecular epidemiology methods allowed
assessment of current trends and risk factors for
subpopulation groups in Manitoba for contracting TB.
Retrospective studies such as this one using stored RFLP
data have shown invaluable to identify both clinical and
epidemiological risk factors for clustering, and have been
used extensively to study other populations within San
Francisco, New York and the Netherlands [17,19,28,29].
This information helps assess the effectiveness and possi-
ble limitations of the Manitoba TB control programs.
Elimination of TB has been defined as less than 1 case per
100,000 population per year [6,8]. By this standard,
recent transmission to Canadian-born non-treaty status
individuals has been nearly eliminated, reaching inci-
dence rates of only 3.3 per 100,000. Complete elimina-
tion of TB in Manitoba has been targeted for 2010, with
5% reduction in incidence per year goal [6,8], but with the
high incidence rates in the remaining two sub-popula-
tions, this will be a difficult task. Targeting and intensify-
ing control measures in the immigrant and treaty status
Aboriginal subpopulations should be a priority in striving
for the goal of tuberculosis elimination in Manitoba.
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